Skip to main content
OpenTrials
Completed

NCT Number: NCT04343898

Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19

Multicenter observational/registry study of the clinical features and outcomes of critically ill patients with COVID-19.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Infection Coronaviridae Infections Coronavirus Infections Infections Nidovirales Infections RNA Virus Infections Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

About this study

The goals of this project are to determine the independent risk factors for hospital mortality and acute organ injury, and to identify treatment strategies associated with improved survival. Additionally, we will assess outcomes according to differences in geographic and institutional parameters.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

(each of the following):

  • Adults (aged ≥18 years)
  • Laboratory-confirmed diagnosis of COVID-19
  • Hospitalized in the ICU for illness related to COVID-19

Exclusion criteria

-None

Treatment and study plan

No intervention

Other

Observational

Primary outcomes

  1. 28-Day Mortality

    Time frame: 28-days from the day of ICU admission

Secondary outcomes

  1. 60-Day Mortality

    Time frame: 60-days from the day of ICU admission

  2. 90-Day Mortality

    Time frame: 90-days from the day of ICU admission

Sponsors and collaborators

Lead sponsor

Brigham and Women's Hospital

Other

Collaborators

  • Baylor College of Medicine
  • Baylor Health Care System
  • Beth Israel Deaconess Medical Center
  • Cook County Hospital
  • Duke University
  • Georgetown University
  • Hackensack Meridian Health
  • Hackensack mountainside hospital
  • Icahn School of Medicine at Mount Sinai
  • Indiana University Health Methodist Hospital
  • Johns Hopkins University
  • Loma Linda University
  • Mayo Clinic
  • Medical College of Wisconsin
  • Montefiore Medical Center
  • NYU Langone Health
  • New Jersey Medical School
  • Northwestern University
  • Ochsner Health System
  • Oregon Health and Science University
  • Renown Health
  • Rush University Medical Center
  • Rutgers Robert Wood Johnson Medical School
  • Stanford University
  • Temple University
  • The Cooper Health System
  • Tufts Medical Center
  • Tulane University
  • University Hospitals Cleveland Medical Center
  • University Medical Center of Southern Nevada
  • University of Alabama at Birmingham
  • University of California, Davis
  • University of California, Los Angeles
  • University of California, San Diego
  • University of California, San Francisco
  • University of Chicago
  • University of Colorado, Denver
  • University of Florida
  • University of Illinois at Chicago
  • University of Kentucky
  • University of Miami
  • University of Michigan
  • University of North Carolina, Chapel Hill
  • University of Oklahoma
  • University of Pennsylvania
  • University of Pittsburgh Medical Center
  • University of Tennessee
  • University of Texas, Southwestern Medical Center at Dallas
  • University of Washington
  • Weill Medical College of Cornell University
  • Yale University

Registry information

Acronym: STOP-COVID

Important dates

Study start
2020
Primary completion
2020
Study completion
2023
First posted
Apr 13, 2020
Registry last updated
Aug 9, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.